Efficacy and safety of atezolizumab–bevacizumab vs pembrolizumab-lenvatinib in unresectable hepatocellular carcinoma: a retrospective, cohort study by Zili Hu, Zili Hu, Zili Hu, Zhoutian Yang, Zhoutian Yang, Zhoutian Yang, Zibo Fu, Yizhen Fu, Yizhen Fu, Yizhen Fu, Zeliang Ma, Zhongguo Zhou, Zhongguo Zhou, Zhongguo Zhou, Minshan Chen, Minshan Chen, Minshan Chen, Yaojun Zhang, Yaojun Zhang, Yaojun Zhang

Get full text